The Conversation We Need to Have About Suboxone
By: Zac Clark I was grateful to see Congress recently remove the need for an X-Waiver to prescribe buprenorphine to treat opioid use disorder – a major win for access – but I was deeply disappointed by the abrasive ad campaign that Ophelia launched touting it as the sole path to recovery. It’s time to have a more nuanced conversation about Suboxone: